36.59
Medline Inc stock is traded at $36.59, with a volume of 5.17M.
It is up +0.00% in the last 24 hours and down -12.96% over the past month.
Medline is the largest provider of medical-surgical products and supply chain solutions in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front-line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.
See More
Previous Close:
$36.59
Open:
$36.2
24h Volume:
5.17M
Relative Volume:
0.65
Market Cap:
$32.10B
Revenue:
$29.14B
Net Income/Loss:
$1.07B
P/E Ratio:
30.60
EPS:
1.1956
Net Cash Flow:
$1.05B
1W Performance:
+3.71%
1M Performance:
-12.96%
6M Performance:
-14.67%
1Y Performance:
+0.00%
Medline Inc Stock (MDLN) Company Profile
Name
Medline Inc
Sector
Industry
Phone
847-949-3000
Address
3 LAKES DRIVE, NORTHFIELD
Compare MDLN vs ISRG, BDX, ALC, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
MDLN
Medline Inc
|
36.59 | 28.58B | 29.14B | 1.07B | 1.05B | 1.1956 |
|
ISRG
Intuitive Surgical Inc
|
366.70 | 132.30B | 11.03B | 3.16B | 3.22B | 8.7251 |
|
BDX
Becton Dickinson Co
|
184.74 | 51.11B | 21.37B | 1.41B | 3.07B | 3.9437 |
|
ALC
Alcon Inc
|
70.50 | 35.25B | 10.63B | 819.00M | 1.59B | 1.6577 |
|
RMD
Resmed Inc
|
228.35 | 32.95B | 5.54B | 1.52B | 1.74B | 10.37 |
Medline Inc Stock (MDLN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-11-26 | Resumed | Citigroup | Buy |
| Feb-05-26 | Initiated | Tigress Financial | Buy |
| Jan-21-26 | Reiterated | BTIG Research | Buy |
| Jan-12-26 | Initiated | Citigroup | Buy |
| Jan-12-26 | Initiated | Deutsche Bank | Hold |
| Jan-12-26 | Initiated | Evercore ISI | Outperform |
| Jan-12-26 | Initiated | Goldman | Buy |
| Jan-12-26 | Initiated | JP Morgan | Overweight |
| Jan-12-26 | Initiated | Jefferies | Buy |
| Jan-12-26 | Initiated | Leerink Partners | Outperform |
| Jan-12-26 | Initiated | Mizuho | Outperform |
| Jan-12-26 | Initiated | Morgan Stanley | Overweight |
| Jan-12-26 | Initiated | Piper Sandler | Overweight |
| Jan-12-26 | Initiated | RBC Capital Mkts | Outperform |
| Jan-12-26 | Initiated | Robert W. Baird | Outperform |
| Jan-12-26 | Initiated | Rothschild & Co Redburn | Neutral |
| Jan-12-26 | Initiated | Stifel | Buy |
| Jan-12-26 | Initiated | TD Cowen | Buy |
| Jan-12-26 | Initiated | Truist | Buy |
| Jan-12-26 | Initiated | UBS | Buy |
| Jan-12-26 | Initiated | Wells Fargo | Equal Weight |
| Jan-12-26 | Initiated | William Blair | Outperform |
| Jan-12-26 | Initiated | Wolfe Research | Outperform |
View All
Medline Inc Stock (MDLN) Latest News
Washington Trust Advisors Inc. Makes New $5.37 Million Investment in Medline $MDLN - MarketBeat
H&F Corporate Investors X Ltd. Sells 15,599,171 Shares of Medline $MDLN - MarketBeat
Medline Inc. (MDLN) Faces Securities Law Investigation After FDA Warning Letters Trigger Stock Drop - kalkine.ca
Artisan Sold Medline (MDLN) as Cost Pressures Delayed the Company’s Profit Recovery - Yahoo Finance
Kaplan Fox Alerts Investors of Medline Inc. (NASDAQ: MDLN) to Possible Securities Law Violations - newmediawire.com
Medline : Mercy Regional Medical Center selects Medline as its Prime Vendor - marketscreener.com
Medline announces participation in the Morgan Stanley 24th Annual Global Healthcare Conference - The Manila Times
Kaplan Fox is Investigating Medline Inc. (NASDAQ: MDLN) for Possible Securities Law Violations - Barchart.com
With its first Prime Vendor deal now active, Medline Canada enters the logistics arena - Medline Newsroom
Pelham Capital Ltd. Takes Position in Medline $MDLN - MarketBeat
Bank of New York Mellon Corp Takes Position in Medline $MDLN - MarketBeat
Medline rises as investors weigh new customer wins and post-earnings reset - Quiver Quantitative
Medline stock reiterated at Buy by BTIG after Illinois facility tour - Investing.com Canada
Kaplan Fox is Investigating Possible Securities Law Violations against Medline Inc. (NASDAQ: MDLN) - Barchart.com
MDLN Stock Price and Chart — NASDAQ:MDLN - TradingView
MDLN Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages Medline Inc. (MDLN) Investors to Contact the Firm - Barchart.com
Medline Inc. (NASDAQ: MDLN) insider logs new share dealings - Stock Titan
Medline (MDLN) CEO awarded 764K units tied to stock price - Stock Titan
Why Medline (MDLN) Stock Is Up Today - Quiver Quantitative
MDLN Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages Medline Inc. (MDLN) Investors to Contact the Firm - NewMediaWire
Kaplan Fox Announces an Investigation of Medline Inc. (NASDAQ: MDLN) on Behalf of Investors - Barchart.com
MDLN Investigation: Kessler Topaz Meltzer & Check, LLP Encourages Medline Inc. (MDLN) Investors to Contact the Firm - Barchart.com
MDLN News Today | Why did Medline stock go down today? - MarketBeat
Medline stock drops over 7% after FDA cites maj... - Pluang
Medline tallies tariff refunds as Q2 sales rise 11.6% - Digital Commerce 360
MDLN Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages Medline Inc. (NASDAQ: MDLN) Investors to Contact the Firm - PR Newswire
Medline (NASDAQ:MDLN) Major Shareholder Sells $3,580,000.00 in Stock - MarketBeat
Medline (NASDAQ:MDLN) Major Shareholder Private Ltd Gic Sells 1,500,000 Shares of Stock - MarketBeat
GIC-tied Medline Inc. (MDLN) sells 1.6M shares at $35.80 in August 2026 - Stock Titan
Medline Inc. (MDLN) Drops 2.41% to $34.88, Testing Key Support at $33.14Bull Pennant - dars.gov.et
Medline Inc. (MDLN) Stock Plummets 7% Amid FDA Warning Letter and Securities Law Probe - Kalkine Media
Kaplan Fox Notifies Investors of Medline Inc. (NASDAQ: MDLN) of a - The National Law Review
Medline Inc. (MDLN) Shares Drop 7% After FDA Warning Letter Triggers Securities Law Investigation - kalkine.ca
Tigress Financial Adjusts Medline Price Target to $55 From $62, Maintains Buy Rating - marketscreener.com
Kaplan Fox Encourages Investors of Medline Inc. (NASDAQ: MDLN) to - The National Law Review
MDLN Investigation: Kessler Topaz Meltzer & Check, LLP Encourages Medline Inc. (NASDAQ: MDLN) Investors to Contact the Firm - Morgan County Citizen
Kaplan Fox is Investigating Medline Inc. (NASDAQ: MDLN) for Potential Securities Law ViolationsInvestors are Encouraged to Contact the Firm - The Globe and Mail
Medline Convenience Kits Impacted By Contamination In Recalled Becton Dickinson Products - Benzinga
Medline Inc. Class A Common Stock (NASDAQ: MDLN) Stock Price, News & Analysis - Kalkine
Medline faces securities probe after FDA cites manufacturing violations, stock drops 7%. - pluang.com
Kaplan Fox Investigates Medline Inc. Over Alleged Securities Violations Following FDA Warning Letters - kalkine.ca
Medline Inc Stock (MDLN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):